{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:05:59Z","timestamp":1787537159954,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["856620"],"award-info":[{"award-number":["856620"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-024-01026-6","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T06:01:49Z","timestamp":1710136909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Large differencies in age-specific survival in multiple myeloma in the nordic countries"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-3316","authenticated-orcid":false,"given":"Kari","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Zitricky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8939-1586","authenticated-orcid":false,"given":"Raija","family":"Silvennoinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2131-731X","authenticated-orcid":false,"given":"Annette","family":"Vangsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"1026_CR1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/ijc.33762","volume":"149","author":"K Hemminki","year":"2021","unstructured":"Hemminki K, F\u00f6rsti A, Houlston R, Sud A. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases. Int J Cancer. 2021;149:1980\u201396.","journal-title":"Int J Cancer"},{"key":"1026_CR2","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111:2962\u201372.","journal-title":"Blood"},{"key":"1026_CR3","doi-asserted-by":"crossref","unstructured":"Ruotsalainen J, Lehmus L, Putkonen M, Lievonen J, Kallio A, Raittinen P, et al. Recent trends in incidence, survival and treatment of multiple myeloma in Finland - a nationwide cohort study. Ann Hematol. 2023. (in press).","DOI":"10.1007\/s00277-023-05571-1"},{"key":"1026_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3324\/haematol.2017.178103","volume":"103","author":"CH Blimark","year":"2018","unstructured":"Blimark CH, Turesson I, Genell A, Ahlberg L, Bj\u00f6rkstrand B, Carlson K, et al. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry. Haematologica. 2018;103:506\u201313.","journal-title":"Haematologica"},{"key":"1026_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/ejh.13707","volume":"108","author":"CH Blimark","year":"2022","unstructured":"Blimark CH, Vangsted AJ, Klausen TW, Gregersen H, Szabo AG, Hermansen E, et al. Outcome data from >10,000 multiple myeloma patients in the Danish and Swedish national registries. Eur J Haematol. 2022;108:99\u2013108.","journal-title":"Eur J Haematol"},{"key":"1026_CR6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3324\/haematol.2021.280424","volume":"108","author":"KLF Moore","year":"2023","unstructured":"Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, et al. Improved survival in myeloma patients-a nationwide registry study of 4,647 patients \u226575 years treated in Denmark and Sweden. Haematologica. 2023;108:1640\u201351.","journal-title":"Haematologica"},{"key":"1026_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96804-8","volume":"11","author":"K Hemminki","year":"2021","unstructured":"Hemminki K, F\u00f6rsti A, Hansson M. Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016. Sci Rep. 2021;11:17272.","journal-title":"Sci Rep."},{"key":"1026_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41375-023-01852-w","volume":"37","author":"K Hemminki","year":"2023","unstructured":"Hemminki K, Hemminki J, F\u00f6rsti A, Sud A. Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. Leukemia. 2023;37:854\u201363.","journal-title":"Leukemia"},{"key":"1026_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0323-4","volume":"10","author":"D Pulte","year":"2020","unstructured":"Pulte D, Jansen L, Brenner H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood cancer J. 2020;10:56.","journal-title":"Blood cancer J"},{"key":"1026_CR10","unstructured":"Lar\u00f8nningen SAG, Bray F, Engholm G, Ervik M, Gu\u00f0mundsd\u00f3ttir EM, Gulbrandsen J, et al. NORDCAN: cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 9.3 (02.10.2023). 2023."},{"key":"1026_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bjh.13537","volume":"171","author":"D Pulte","year":"2015","unstructured":"Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, et al. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 2015;171:189\u201396.","journal-title":"Br J Haematol"},{"key":"1026_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/0284186X.2017.1407039","volume":"57","author":"E Pukkala","year":"2018","unstructured":"Pukkala E, Engholm G, Hojsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic cancer registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57:440\u201355.","journal-title":"Acta Oncol"},{"key":"1026_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.healthpol.2011.11.001","volume":"105","author":"HB Probst","year":"2012","unstructured":"Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians\u2013a national Danish project. Health Policy. 2012;105:65\u201370.","journal-title":"Health Policy"},{"key":"1026_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2147\/CLEP.S99463","volume":"8","author":"P Gimsing","year":"2016","unstructured":"Gimsing P, Holmstr\u00f6m MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, et al. The Danish National Multiple Myeloma Registry. Clin Epidemiol. 2016;8:583\u20137.","journal-title":"Clin Epidemiol"},{"key":"1026_CR15","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2217\/fon-2023-0120","volume":"19","author":"J Vikkula","year":"2023","unstructured":"Vikkula J, Uusi-Rauva K, Ranki T, Toppila I, Aalto-Set\u00e4l\u00e4 M, Pousar K, et al. Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland. Future Oncol. 2023;19:2029\u201343.","journal-title":"Future Oncol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01026-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T06:02:11Z","timestamp":1710136931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01026-6","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}